Tony Eight Lin

1.2k total citations
60 papers, 881 citations indexed

About

Tony Eight Lin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Tony Eight Lin has authored 60 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Tony Eight Lin's work include Histone Deacetylase Inhibitors Research (17 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (9 papers). Tony Eight Lin is often cited by papers focused on Histone Deacetylase Inhibitors Research (17 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (9 papers). Tony Eight Lin collaborates with scholars based in Taiwan, China and United States. Tony Eight Lin's co-authors include Kai‐Cheng Hsu, Jing‐Ping Liou, Wen‐Chang Chang, Jan‐Jong Hung, Ming-Jer Young, Shiow‐Lin Pan, Wei‐Jan Huang, Mei-Jung Lai, Chia‐Ron Yang and Wei‐Chun HuangFu and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Tony Eight Lin

56 papers receiving 871 citations

Peers

Countries citing papers authored by Tony Eight Lin

Since Specialization

Citations

This map shows the geographic impact of Tony Eight Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Eight Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Eight Lin more than expected).

Fields of papers citing papers by Tony Eight Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Eight Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Eight Lin. The network helps show where Tony Eight Lin may publish in the future.

Co-authorship network of co-authors of Tony Eight Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Eight Lin. A scholar is included among the top collaborators of Tony Eight Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Eight Lin. Tony Eight Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening 2025 ·Advanced Science ·Chunlin Yang, (unknown), Huang‐Ju Tu, (unknown), Tony Eight Lin, (unknown), Mu‐Chun Li, (unknown), Jui‐Hua Hsieh, Ming‐Chin Yu, Sen‐Yung Hsieh, Hsing‐Pang Hsieh, Shiow‐Lin Pan, Kai‐Cheng Hsu	0
2	Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma 2024 ·International Journal of Biological Macromolecules ·(unknown), (unknown), Wei‐Chun HuangFu, Tony Eight Lin, Tzu-Ying Sung, Mu‐Chun Li, (unknown), Yu-Wei Chang, (unknown), Hsing‐Pang Hsieh, Kai‐Cheng Hsu, Shiow‐Lin Pan	1
3	HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids 2024 ·European Journal of Medicinal Chemistry ·(unknown), I‐Chung Chen, (unknown), Mei-Jung Lai, Zhengyang Liu, Kelvin K. Tsai, (unknown), (unknown), Er-Chieh Cho, (unknown), Tony Eight Lin, Kai‐Cheng Hsu, (unknown), Jing‐Ping Liou	6
4	An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors 2024 ·Protein Science ·Tony Eight Lin, (unknown), Wei‐Chun HuangFu, (unknown), (unknown), (unknown), (unknown), Jui‐Hua Hsieh, Shiow‐Lin Pan, Chia‐Ron Yang, Wei‐Jan Huang, Kai‐Cheng Hsu	4
5	Targeting formyl peptide receptor 1 with anteiso‐C13‐surfactin for neutrophil‐dominant acute respiratory distress syndrome 2023 ·British Journal of Pharmacology ·Shun‐Chin Yang, Yi‐Hsuan Wang, Chiu‐Ming Ho, Yung‐Fong Tsai, Ping‐Jyun Sung, Tony Eight Lin, Tsong‐Long Hwang	9
6	Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Bin Qian, Mei‐Jung Lai, (unknown), Tsung‐I Hsu, Tony Eight Lin, Kai‐Cheng Hsu, Kuo‐Hsiang Chuang, Jing‐Ping Liou, Jean C. Shih	13
7	Exploration of anti‐leukemic effect of soft coral‐derived 13‐acetoxysarcocrassolide: Induction of apoptosis via oxidative stress as a potent inhibitor of heat shock protein 90 and topoisomerase II 2023 ·The Kaohsiung Journal of Medical Sciences ·(unknown), Mei‐Chin Lu, Kai‐Cheng Hsu, Mohamed El‐Shazly, (unknown), Tzu‐Yung Lin, Shou‐Ping Shih, Tony Eight Lin, Zhi‐Hong Wen, Yu‐Chen S. H. Yang, Yi‐Chang Liu	2
8	Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), (unknown), Sung‐Bau Lee, Kai‐Cheng Hsu, Ling‐Wei Hsin, (unknown), Tony Eight Lin, (unknown), Liang‐Chieh Chen, (unknown), Andrew H.‐J. Wang, Wei‐Jan Huang	4
9	The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Ting‐Yi Sung, Shiow‐Lin Pan, Wei‐Jan Huang, Kai‐Cheng Hsu, (unknown), Tony Eight Lin, (unknown), Chia‐Ron Yang	14
10	Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Kai‐Cheng Hsu, (unknown), (unknown), Tony Eight Lin, Tzu-Ying Sung, (unknown), (unknown), Chia‐Ron Yang, Wei‐Jan Huang	9
11	O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia 2022 ·Phytomedicine ·(unknown), Yiwen Wu, (unknown), Min‐Wu Chao, Huang‐Ju Tu, Liang‐Chieh Chen, Tony Eight Lin, Tzu-Ying Sung, (unknown), (unknown), Wei‐Jan Huang, Chia‐Ron Yang, Wei‐Chun HuangFu, Shiow‐Lin Pan, Kai‐Cheng Hsu	7
12	Structure-based virtual screening discovers novel kidney-type glutaminase inhibitors 2022 ·Biomedicine & Pharmacotherapy ·(unknown), Hsin‐Yi Chang, Tony Eight Lin, (unknown), Shih‐Min Hsia, Kai‐Cheng Hsu, Tsui‐Chin Huang	5
13	Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma 2021 ·European Journal of Medicinal Chemistry ·Kunal Nepali, Tsung‐I Hsu, Chien‐Ming Hsieh, (unknown), Mei-Jung Lai, Kai‐Cheng Hsu, Tony Eight Lin, Jian‐Ying Chuang, Jing‐Ping Liou	18
14	Magnolol, A Novel Antagonist of Thrombin and PAR-1, Inhibits Thrombin-Induced Connective Tissue Growth Factor (CTGF) Expression in Vascular Smooth Muscle Cells and Ameliorate Pathogenesis of Restenosis in Rats 2020 ·Applied Sciences ·Wen‐Chin Ko, Chia‐Ti Tsai, Kai‐Cheng Hsu, Yu‐Che Cheng, Tony Eight Lin, Yi‐Ling Chen, Chuang-Ye Hong, Wan‐Jung Lu, Chun‐Ming Shih, Ting‐Lin Yen	1
15	Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo 2020 ·European Journal of Medicinal Chemistry ·Ritu Ojha, Kunal Nepali, Chun‐Han Chen, Kai‐Hsiang Chuang, (unknown), Tony Eight Lin, Kai‐Cheng Hsu, Min‐Wu Chao, Mei-Jung Lai, Mei-Hsiang Lin, Han-Li Huang, (unknown), Shiow‐Lin Pan, Mei-Chuan Chen, Jing‐Ping Liou	35
16	A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors 2020 ·Scientific Reports ·Kai‐Cheng Hsu, Wei‐Chun HuangFu, Tony Eight Lin, Min‐Wu Chao, (unknown), Yi‐Ying Chen, Shiow‐Lin Pan, (unknown), Shey‐Cherng Tzou, Chung‐Ming Sun, Jinn‐Moon Yang	8
17	The role of ubiquitin-specific peptidases in cancer progression 2019 ·Journal of Biomedical Science ·Ming-Jer Young, Kai‐Cheng Hsu, Tony Eight Lin, Wen‐Chang Chang, Jan‐Jong Hung	118
18	Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation 2018 ·Frontiers in Pharmacology ·Liang‐Chieh Chen, (unknown), Changyi Liu, (unknown), (unknown), Jing‐Ru Weng, (unknown), Wen‐Chi Hou, Tony Eight Lin, (unknown), (unknown), Wei‐Jan Huang, Kai‐Cheng Hsu	9
19	Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities 2017 ·European Journal of Medicinal Chemistry ·Shi-Wei Chao, Liang‐Chieh Chen, (unknown), Changyi Liu, Tony Eight Lin, Jih‐Hwa Guh, Chen‐Yu Wang, (unknown), Kai‐Cheng Hsu, Wei‐Jan Huang	20
20	Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach 2017 ·Scientific Reports ·Kai‐Cheng Hsu, Changyi Liu, Tony Eight Lin, Jui-Hua Hsieh, (unknown), (unknown), Jinn‐Moon Yang, Wei‐Jan Huang	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact